Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Hypertrophy and CYP2C9[original query] |
---|
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Journal of hypertension 2002 Oct 20 (10): 2089-93. Hallberg Pär, Karlsson Julia, Kurland Lisa, Lind Lars, Kahan Thomas, Malmqvist Karin, Ohman K Peter, Nyström Fredrik, Melhus Håk |
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. Pharmacogenomics and personalized medicine 2018 4 11 51-58. Silvado Carlos Eduardo, Terra Vera Cristina, Twardowschy Carlos Alexand |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: